{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:07:47Z","timestamp":1777637267331,"version":"3.51.4"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Obesity and non-alcoholic fatty liver disease (NAFLD) are known to be closely interlinked; however, the mechanism of their interaction is unclear. This study sought to explore the causal relationship and shared biomarkers in obesity and NAFLD by combining Mendelian randomization (MR) and transcriptomic data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A bidirectional MR analysis was performed using summary statistics data from GWAS database to determine the causal relationship between obesity and NAFLD. Based on transcriptome data from GEO database, candidate genes were identified by combining differential expression analysis and expression level analysis. Subsequently, candidate genes were incorporated into least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature elimination (SVM-RFE) algorithms to recognize shared biomarkers in obesity and NAFLD. The nomograms based on shared biomarkers were generated to predict the probability of developing obesity and NAFLD. Further, enrichment analysis and regulatory network construction were accomplished to excavate deeper into the molecular mechanism of obesity and NAFLD. Ultimately, expression level of shared biomarkers was validated through qRT-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Rusults<\/jats:title>\n                    <jats:p>\n                      MR analysis indicated significant causal effect of obesity on NAFLD (IVW:\n                      <jats:italic>P<\/jats:italic>\n                      = 0.034, OR = 1.252), while no significant causal effect of NAFLD on obesity (IVW:\n                      <jats:italic>P<\/jats:italic>\n                      &amp;gt; 0.05). Subsequently, based on the results of LASSO and SVM-RFE, we gained two shared biomarkers (NCAPH and IRS2) in obesity and NAFLD, and IRS2 was down-regulated and NCAPH was up-regulated in disease (obesity\/NAFLD) samples. Receiver operating characteristic curves manifested that the efficacy of NCAPH and IRS2 in distinguishing between disease (obesity\/NAFLD) and normal samples was all excellent. Besides, the nomograms constructed based on two shared biomarkers were reliable and had high reference value for predicting obesity and NAFLD. Enrichment analysis revealed that shared biomarkers could influence the development of both obesity and NAFLD via the \u201cECM-receptor interaction,\u201d \u201cJak-STAT signaling pathway,\u201d etc. In lncRNA-miRNA-mRNA network, lncRNAs (NEAT1, MALAT1, and FTX) could simultaneously regulate two shared biomarker via hsa-miR-493-5p. Ultimately, qRT-PCR results revealed that NCAPH was in line with the bioinformatics results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study discovered causal effect of obesity on NAFLD and identified two shared biomarkers (NCAPH and IRS2) in two diseases, providing new insights for further explore the pathogenesis of both diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1780686","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:06:09Z","timestamp":1777442769000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of shared biomarkers in obesity and non-alcoholic fatty liver disease: a comprehensive analysis of Mendelian randomization and transcriptomic data"],"prefix":"10.3389","volume":"13","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinda","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Niu","sequence":"additional","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WenJun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Ma","sequence":"additional","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"Han","sequence":"additional","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"B1","volume-title":"Obesity and Overweight.","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2016.5898","article-title":"Association of neighborhood walkability with change in overweight, obesity, and diabetes.","volume":"315","author":"Creatore","year":"2016","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments.","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mpmed.2014.11.003","article-title":"Medical consequences of obesity.","volume":"43","author":"Finer","year":"2015","journal-title":"Medicine."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.","volume":"403","year":"2024","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0167-6296(97)00005-2","article-title":"Disability-adjusted life years: a critical review.","volume":"16","author":"Anand","year":"1997","journal-title":"J Health Econ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease.","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4254\/wjh.v7.i6.846","article-title":"Non-alcoholic fatty liver disease: the diagnosis and management.","volume":"7","author":"Abd El-Kader","year":"2015"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3390\/ijms21072296","article-title":"Targeting of secretory proteins as a therapeutic strategy for treatment of nonalcoholic steatohepatitis (NASH).","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s00125-019-04972-0","article-title":"Dietary inflammatory index and type 2 diabetes risk in a prospective cohort of 70,991 women followed for 20 years: the mediating role of BMI.","volume":"62","author":"Laouali","year":"2019","journal-title":"Diabetologia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/MCB.21.1.26-38.2001","article-title":"Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.","volume":"21","author":"Tsuruzoe","year":"2001","journal-title":"Mol Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"a041302","DOI":"10.1101\/cshperspect.a041302","article-title":"Mendelian randomization.","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1156381","DOI":"10.3389\/fendo.2023.1156381","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: an observational and mendelian randomization study.","volume":"14","author":"Yu","year":"2023","journal-title":"Front Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0302209","DOI":"10.1371\/journal.pone.0302209","article-title":"Aminotransferases as causal factors for metabolic syndrome: a bidirectional mendelian randomization study.","volume":"19","author":"Lingyu","year":"2024","journal-title":"PLoS One."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife."},{"key":"B16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2.","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinform."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data.","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinform."},{"key":"B24","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data.","volume":"2","author":"Wu","year":"2021","journal-title":"Innov."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent.","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw."},{"key":"B26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3892\/mmr.2019.10841","article-title":"21-gene support vector machine classifier and a 10-gene risk score system constructed for patients with gastric cancer.","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol Med Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves.","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7576","DOI":"10.1111\/jcmm.15393","article-title":"DNA methylation profiling to predict recurrence risk in stage I lung adenocarcinoma: development and validation of a nomogram to clinical management.","volume":"24","author":"Ma","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics.","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metab, Clin Exp."},{"key":"B31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"159209","DOI":"10.1016\/j.bbalip.2022.159209","article-title":"Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis.","volume":"1867","author":"Hughey","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/jcb.30247","article-title":"Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD\/MAFLD).","volume":"123","author":"Flessa","year":"2022","journal-title":"J Cell Biochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci CMLS."},{"key":"B37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-981-10-8684-7_9","article-title":"Microbiota, obesity and NAFLD.","volume":"1061","author":"Lau","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/ijms17040481","article-title":"Diet, microbiota, obesity, and NAFLD: a dangerous quartet.","volume":"17","author":"Machado","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5152\/tjg.2014.7886","article-title":"Role of gut microbiota: obesity and NAFLD.","volume":"25","author":"Gangarapu","year":"2014","journal-title":"Turk J Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/nu10101457","article-title":"Gut microbiota\u2019s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics.","volume":"10","author":"Meng","year":"2018","journal-title":"Nutrients."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD.","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1152\/ajpendo.00336.2023","article-title":"Relationship between serum \u03b2-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD.","volume":"326","author":"Moore","year":"2024","journal-title":"Am J Physiol, Endocrinol Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12072-023-10596-9","article-title":"Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study.","volume":"18","author":"Jin","year":"2024","journal-title":"Hepatol Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/biomedicines10051184","article-title":"Premenopausal syndrome and NAFLD: a new approach based on gender medicine.","volume":"10","author":"Carrieri","year":"2022","journal-title":"Biomedicines."},{"key":"B45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12876-023-02997-9","article-title":"Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease.","volume":"23","author":"Cao","year":"2023","journal-title":"BMC Gastroenterol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e003649","DOI":"10.1136\/bmjdrc-2023-003649","article-title":"Genetic variant rs9939609 in FTO is associated with body composition and obesity risk in Korean females.","volume":"11","author":"Park","year":"2023","journal-title":"BMJ Open Diabetes Res Care."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","article-title":"Interaction between estrogen receptor-\u03b1 and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.","volume":"29","author":"Cherubini","year":"2023","journal-title":"Nat Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.tig.2024.02.009","article-title":"Genetic variation drives differences in obesity-related gene regulation.","volume":"40","author":"Kaikkonen","year":"2024","journal-title":"Trends Genet TIG."},{"key":"B49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ijo.0802830","article-title":"Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids.","volume":"29","author":"Atkinson","year":"2005","journal-title":"Int J Obes."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1515\/ijamh-2018-0110","article-title":"High adenovirus 36 seroprevalence among a population of hispanic American youth.","volume":"33","author":"LaVoy","year":"2018","journal-title":"Int J Adolesc Med Health."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/v7072787","article-title":"Adenovirus 36 and obesity: an overview.","volume":"7","author":"Ponterio","year":"2015","journal-title":"Viruses."},{"key":"B52","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1473-3099(11)70274-2","article-title":"A framework for identification of infections that contribute to human obesity.","volume":"11","author":"Dhurandhar","year":"2011","journal-title":"Lancet Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/v13071285","article-title":"Findings from studies are congruent with obesity having a viral origin, but what about obesity-related NAFLD?","volume":"13","author":"Tarantino","year":"2021","journal-title":"Viruses."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41366-021-00805-6","article-title":"Adenovirus 36 prevalence and association with human obesity: a systematic review.","volume":"45","author":"da Silva Fernandes","year":"2021","journal-title":"Int J Obes."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41366-018-0062-9","article-title":"Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers.","volume":"2018","author":"Honma","year":"2005","journal-title":"Int J Obes."},{"key":"B56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/13813455.2011.557386","article-title":"IRS2 and PTP1B: two opposite modulators of hepatic insulin signalling.","volume":"117","author":"Valverde","year":"2011","journal-title":"Arch Physiol Biochem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI95802","article-title":"Hippo-mediated suppression of IRS2\/AKT signaling prevents hepatic steatosis and liver cancer.","volume":"128","author":"Jeong","year":"2018","journal-title":"J Clin Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12967-020-02225-y","article-title":"Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2\/AKT pathway.","volume":"18","author":"Chi","year":"2020","journal-title":"J Transl Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1042\/CS20257727","article-title":"Molecular mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD): functional analysis of glucose and fructose metabolism pathways.","volume":"139","author":"Rabbani","year":"2025","journal-title":"Clin Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1589695","DOI":"10.3389\/fendo.2025.1589695","article-title":"Mechanisms and therapeutics of insulin signaling transduction genes in diabetic cardiomyopathy: a comprehensive updated review.","volume":"16","author":"He","year":"2025","journal-title":"Front Endocrinol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13048-025-01659-6","article-title":"NCAPH promotes glucose metabolism reprogramming and cell stemness in ovarian cancer cells through the MEK\/ERK\/PD-L1 pathway.","volume":"18","author":"Qi","year":"2025","journal-title":"J Ovarian Res."},{"key":"B62","first-page":"164","article-title":"[Research progress on the mechanism and targeted therapy of monocytes-macrophages in metabolic associated fatty liver disease].","volume":"42","author":"Ding","year":"2026","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chin J Cell Mol Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41590-025-02255-y","article-title":"Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis.","volume":"26","author":"Martin","year":"2025","journal-title":"Nat Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"8079","DOI":"10.3390\/ijms26168079","article-title":"Geniposide mitigates insulin resistance and hepatic fibrosis via insulin signaling pathway.","volume":"26","author":"Oh","year":"2025","journal-title":"Int J Mol Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"119937","DOI":"10.1016\/j.jep.2025.119937","article-title":"Gan-tang-yi decoction improves hepatic insulin resistance through activation of IRS2\/PI3K\/akt pathway and inhibition of AGEs\/RAGE pathway in cirrhotic rats.","volume":"349","author":"Xu","year":"2025","journal-title":"J Ethnopharmacol."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1780686\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:06:14Z","timestamp":1777442774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1780686\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":65,"alternative-id":["10.3389\/fnut.2026.1780686"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1780686","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"1780686"}}